NMPA Approval

Piperacillin Sodium and Tazobactam Sodium for Injection

Approval Number

国药准字H20093316

Company青州尧王制药有限公司

Registration Date

September 11, 2023

Drug Information

Generic Name

注射用哌拉西林钠他唑巴坦钠

Dosage Form

注射剂

Strength

2.25g(C23H27N5O7S 2.0g与C10H12N4O5S 0.25g)

Drug Type

化学药品

Registration Date

September 11, 2023

Company Information

Applicant Company

Company Name青州尧王制药有限公司

Company Address

山东省青州市尧王山西路1号

Manufacturing Company

Company Name青州尧王制药有限公司

Company Address

山东省青州市王母宫街799号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用哌拉西林钠他唑巴坦钠 - NMPA 批准文号 | MedPath